A Forbes Asia 100 to Watch company AI+ laboratory diagnostics China’s first Class III AI Medical Device Registration Certificate in the IVD field

A Forbes Asia “100 companies to Watch” company who specializes in the research and development of artificial intelligence technologies in laboratory diagnostics, the production of related diagnostics hardware and provision of technical services. Headquartered in Beijing, focusing on AI-powered blood specimen handling and high-throughput blood morphology processing technology. The company’s first product Cygnus is a high-throughput blood smear analyzer that obtained China’s first Class III, AI-based medical device market license in the field of in-vitro diagnostics (IVD). The product can detect hematologic diseases with an accuracy over 95%, and has been deployed in over 100 renowned domestic medical institutions. We're having business collaboration across the South Asia, Europe and Latin America. The company is funded by renowned investors such as ZhenFund Miracle Plus (former Y Combinator China) and Danaher Group. 60% of employees graduated from world-class universities.

Artificial Intelligence, Banking, Finance & Insurance, Healthcare, Manufacturing, Technology, Big Data & Analytics, Data Centres, HealthTech